Longitudinal Associations of Mental Disorders With Dementia: 30-Year Analysis of 1.7 Million New Zealand Citizens.
Leah S Richmond-Rakerd, Stephanie D'Souza, Barry J Milne...
https://pubmed.ncbi.nlm.nih.gov/35171209/Actively Recruiting
Led by Hospital Center Guillaume Régnier · Updated on 2025-04-06
30
Participants Needed
1
Research Sites
156 weeks
Total Duration
Researchers are investigating apathy-related neurobehavioral markers in elderly individuals aged 70 to 85 years with bipolar disorder. The goal is to identify reliable signs that may predict a higher risk of progressing to dementia by analyzing motor activity, spoken language, and brain changes using MRI. The study compares elderly bipolar disorder patients with healthy volunteers within the same age range to better understand these markers. Participants will wear a wrist actigraph device for 4 full days to record their body movements. After this period, they will have a 45-minute MRI scan that captures various brain features, including degenerative, inflammatory, vascular, and functional connectivity aspects. The MRI includes several imaging techniques such as anatomical 3DT1, multicompartment models like NODDI, 3D FLAIR, arterial spin labeling, and resting-state BOLD. During the study, participants complete three cognitive tasks assessing verbal memory, verbal fluency, and emotional storytelling. Data from the actimeter and MRI are collected and securely stored for analysis. Researchers will compare actigraphy data from bipolar participants with healthy controls over four days. Speech biomarkers and MRI-derived brain features will also be studied at baseline and at follow-up intervals for bipolar participants. The study includes safety monitoring and lasts up to 36 months for some assessments.
CONDITIONS
Apathy-related Neurobehavioral Markers of Cognitive Decline in Old-age Bipolar Disorders: Proof-of-concept
G
Gabriel RG ROBERT
N
Nathalie AN ALLETON
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Hospital Center Guillaume Régnier
Lead Sponsor
Rennes University Hospital
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 5 days
Participants wear a wrist actigraph for 4 full days to collect activity data before undergoing MRI scans.
1 visit to set up the actigraph and 1 visit to return the device and undergo MRI (about 45 minutes)
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Leah S Richmond-Rakerd, Stephanie D'Souza, Barry J Milne...
https://pubmed.ncbi.nlm.nih.gov/35171209/Osvaldo P Almeida, Kieran McCaul, Graeme J Hankey...
https://pubmed.ncbi.nlm.nih.gov/27482038/Myuri Ruthirakuhan, Nathan Herrmann, Danielle Vieira...
https://pubmed.ncbi.nlm.nih.gov/30910421/Amy L Byers, Kristine Yaffe
https://pubmed.ncbi.nlm.nih.gov/21537355/Jia-Jia Wu, Hui-Xin Wang, Wu Yao...
https://pubmed.ncbi.nlm.nih.gov/32664001/Kathy Dujardin, Pascal Sockeel, Marie Delliaux...
https://pubmed.ncbi.nlm.nih.gov/19908317/J Velosa, A Delgado, E Finger...
https://pubmed.ncbi.nlm.nih.gov/31954065/Allison R Kaup, Amy L Byers, Cherie Falvey...
https://pubmed.ncbi.nlm.nih.gov/26982217/Amber John, Rob Saunders, Roopal Desai...
https://pubmed.ncbi.nlm.nih.gov/36106698/Osvaldo P Almeida, Graeme J Hankey, Bu B Yeap...
https://pubmed.ncbi.nlm.nih.gov/30015397/Hospital Center Guillaume Régnier
Lead Sponsor
Rennes University Hospital
Collaborating Sponsor